Michael Scolaro

Michael Scolaro

Sep 16, 2017

Group 6 Copy 155
3
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Using Nanoparticles to Activate Immune Cells to Fight Tumors

Our lab is developing a new cancer treatment which utilizes the patients own immune system to fight and kill...

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain chemicals...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Backer Badge Funded